BioSpace News Archive

Paper is the first to define the requirements for establishment of dedicated adult sickle cell disease treatment centers

On the heels of a series of successful virtual webinars, The Sickle Cell Foundation of Tennessee will launch the Sickle Cell Today podcast on the KUDZUKIAN Network. The first of the four episode series debuted on Monday, August 10 th and will air once a week going forward. Episodes will focus on pain management, quality of li

Patients taking VILTEPSO showed an increase in dystrophin expression to an average of 5.9% of normal after 20-24 weeks of treatment.

Akero Therapeutics, Inc. (Nasdaq: AKRO), a cardio-metabolic non-alcoholic steatohepatitis (NASH) company developing pioneering medicines designed to restore metabolic balance and improve the overall health of NASH patients, today reported second quarter financial results for the period ending June 30, 2020 .

COVID-19 and the disproportionate impact it has had on racial and ethnic groups has put a spotlight on longstanding healthcare inequalities in the United States.

Elite Pharmaceuticals, Inc. (“Elite” or the “Company”) (OTCQB:ELTP), a specialty pharmaceutical company developing niche generic products, announced today that it will release its 2021 first quarter financial results on Friday, August 14, 2020

Antengene Corporation, a leading innovative hematology and oncology-focused biopharmaceutical company, announced today the authorization of the first-in-human trial of ATG-017 (ERASER trial) by the Australian Therapeutic Goods Administration (TGA).

Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that Quidel has received Health Canada authorization to market and sell the Lyra® Direct SARS-CoV-2 Assay in Canada

Laurel Fuqua, RN, MSN, executive VP and chief clinical officer at Monarch Medical Technologies, will advise diabetes care and education specialists on “Data Visualization Skills for Diabetes Population Health Management” as a speaker on opening day for the Association of Diabetes Care and Education Specialists (ADCES) virtual annual conference- ADCES20.

Golden Helix has secured its reputation as a global leader in Next-Generation Sequencing solutions for over two decades. , they have been included in the esteemed Inc. 5000 list of rapidly growing American companies.